Literature DB >> 17582591

Effect of oriental herbal prescription Guan-Xin-Er-Hao on coronary flow in healthy volunteers and antiapoptosis on myocardial ischemia-reperfusion in rat models.

Jianlei Zhao1, Xi Huang, Wenfu Tang, Ping Ren, Zhihua Xing, Xinqiao Tian, Zhengyan Zhu, Yonggang Wang.   

Abstract

Ischemic heart disease (IHD) is the main cause of death and a major public health problem in the world. The traditional herbal medicinal formula Guan-Xin-Er-Hao (GXEH) has been used in China and East Asia for the treatment of coronary heart disease, however, the underlying cardioprotection mechanisms remain unclear. To make clear the antiischemic mechanism involved, GXEH was orally administered to 15 healthy volunteers. Heart rates (HR), blood pressure and coronary flow (CF) velocity before and 1 h after a single oral dose of GXEH were observed and compared. It was demonstrated that the oral administration of GXEH increased CF acutely in a dose-dependent manner without modification of systemic hemodynamic parameters. Moreover, the myocardial protection function of GXEH was also experimentally examined in ischemia-reperfusion (I/R) rat models. Apoptosis was measured quantitatively by the terminal transferase UTP nick end-labeling (TUNEL) method and confirmed by caspase-3 activity. The infarct size and TUNEL-positive cells of GXEH-treated group (20 g/kg) were reduced significantly, which was consistent with the decreased caspase-3 activity. These suggest that GXEH protects hearts from ischemia injury by increasing CF and reduces infarct size by inhibiting myocardial apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17582591     DOI: 10.1002/ptr.2194

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  8 in total

1.  Effect of Xuefu Zhuyu Capsule (血府逐瘀胶囊) on the symptoms and signs and health-related quality of life in the unstable angina patients with blood-stasis syndrome after percutaneous coronary intervention: A Randomized controlled trial.

Authors:  Fu-yong Chu; Jie Wang; Kui-wu Yao; Zhi-zhong Li
Journal:  Chin J Integr Med       Date:  2010-06-10       Impact factor: 1.978

2.  Neurorescue effect of rosmarinic acid on 6-hydroxydopamine-lesioned nigral dopamine neurons in rat model of Parkinson's disease.

Authors:  Jieyu Wang; Huamin Xu; Hong Jiang; Xixun Du; Peng Sun; Junxia Xie
Journal:  J Mol Neurosci       Date:  2011-12-29       Impact factor: 3.444

3.  Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin II Formula (II) for Coronary Heart Disease.

Authors:  Song Sheng; Zhi-Xu Yang; Feng-Qin Xu; Ye Huang
Journal:  Chin J Integr Med       Date:  2020-05-09       Impact factor: 1.978

Review 4.  Guanxin II (II) for the management of coronary heart disease.

Authors:  Feng Qin; Xi Huang
Journal:  Chin J Integr Med       Date:  2010-01-18       Impact factor: 1.978

5.  Dan-Shen-Yin protects the heart against inflammation and oxidative stress induced by acute ischemic myocardial injury in rats.

Authors:  Kui-Po Yan; Yong Guo; Zhihua Xing; Xi Huang; Shengping Dai; Min Duan; Xinhua Sun; Wei Huang; Weijun Peng
Journal:  Exp Ther Med       Date:  2011-12-05       Impact factor: 2.447

6.  Zenglv Fumai Granule protects cardiomyocytes against hypoxia/reoxygenation-induced apoptosis via inhibiting TRIM28 expression.

Authors:  Xiao-Hua Zhang; Hong-Yu Zhao; Yu Wang; Lin Di; Xin-Yu Liu; Feng Qian; Shu-Rong Liu
Journal:  Mol Med Rep       Date:  2021-01-05       Impact factor: 2.952

Review 7.  Effects and mechanisms of chinese herbal medicine in ameliorating myocardial ischemia-reperfusion injury.

Authors:  Qing Liu; Jiqiang Li; Jing Wang; Jianping Li; Joseph S Janicki; Daping Fan
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-31       Impact factor: 2.629

8.  Pharmacokinetic comparison of the vasorelaxant compound ferulic acid following the administration of Guanxin II to healthy volunteers and patients with angina pectoris.

Authors:  Yun-Hui Li; Xi Huang; Yang Wang; Rong Fan; Hong-Min Zhang; Ping Ren; Yao Chen; Hong-Hao Zhou; Zhao-Qian Liu; Yi-Zeng Liang; Hong-Mei Lu
Journal:  Exp Ther Med       Date:  2013-09-17       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.